New smart drug aims to lower blood sugar with fewer side effects
NCT ID NCT07327281
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 24 times
Summary
This early-stage study tests a new capsule called TQF3250 in 66 healthy adults to see if it is safe and how the body handles it. The drug is designed to help control high blood sugar by targeting a specific receptor, potentially with fewer side effects than current treatments. Participants receive a single dose and are monitored closely for any effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERGLYCEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Drum Tower Hospital Affiliated to Nanjing University School of Medicine
RECRUITINGNanjing, Jiangsu, 210008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.